0001209191-20-017232.txt : 20200309
0001209191-20-017232.hdr.sgml : 20200309
20200309161015
ACCESSION NUMBER: 0001209191-20-017232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200305
FILED AS OF DATE: 20200309
DATE AS OF CHANGE: 20200309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Driscoll Martin J
CENTRAL INDEX KEY: 0001339402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 20698063
MAIL ADDRESS:
STREET 1: C/O JAVELIN PHARMACEUTICALS, INC.
STREET 2: 125 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-05
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001339402
Driscoll Martin J
C/O SPRING BANK PHARMACEUTICALS, INC.
35 PARKWOOD DRIVE, SUITE 210
HOPKINTON
MA
01748
1
1
0
0
President and CEO
Stock Option (Right to Buy)
1.41
2020-03-05
4
A
0
40000
0.00
A
2030-03-04
Common Stock
40000
40000
D
Restricted Stock Units
2020-03-05
4
A
0
40000
0.00
A
Common Stock
40000
40000
D
This option was granted on March 5, 2020, with 25% of the shares subject to the option vesting on March 5, 2021 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of Spring Bank Pharmaceuticals, Inc. common stock.
The restricted stock units will vest in two installments. Fifty percent will vest on March 5, 2021 and the remaining fifty percent will vest on December 31, 2021.
/s/ Lori Firmani, Attorney-in-Fact
2020-03-09